Sustained cytogenetic response after discontinuation of imatinib mesylate in a patient with chronic myeloid leukaemia
Waleed Ghanima, Johannes Kahrs, Tobias Gedde Dahl III, Geir E. TjonnfjordVolume:
72
Year:
2004
Language:
english
Pages:
3
DOI:
10.1111/j.1600-0609.2004.00257.x
File:
PDF, 74 KB
english, 2004